RxDoctor Payments Data

Katie Dye, PA

Physician Assistant · Manistee, MINPI 1760700363

Payments from drug & device makers

$1,600in general payments, 2019–2025

Across 90 payments — averaging $17.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$659
  • GSK$143
  • Lilly USA, LLC$140
  • Novo Nordisk$76
  • Exact Sciences$69
  • Pfizer$62
  • plus $451 from 16 others

What the payments were for

  • Food & beverage$1,600100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,600 in reported general payments places this provider in the 80th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$10,552
Medicare patients
57
Services billed
225

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter132$135,750
JardianceEmpagliflozin93$83,699
MounjaroTirzepatide67$76,738
EliquisApixaban58$51,351
TrulicityDulaglutide44$47,300
TrintellixVortioxetine Hydrobromide38$30,738
OzempicSemaglutide19$18,023
OxycontinOxycodone Hcl25$9,084
XareltoRivaroxaban13$7,676
TradjentaLinagliptin12$5,845
Febuxostat45$4,928
Albuterol Sulfate HfaAlbuterol Sulfate114$4,392
Lantus SolostarInsulin Glargine,hum.Rec.Anlog30$4,272
Omeprazole202$3,630
Levothyroxine Sodium253$3,438

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$143$135,750132 claims
Lilly USA, LLCMounjaro, Trulicity$140$124,039111 claims
Boehringer IngelheimJardiance, Tradjenta$23$89,543105 claims
PfizerEliquis$62$51,35158 claims
Novo NordiskOzempic$76$18,02319 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Manistee

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →